Structural Heart Devices Market Size, Share, Growth Analysis, By Product(Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems), By Procedure(Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty), By Region - Industry Forecast 2024-2031

North America dominated the structural heart devices industry and held the largest revenue share of 40.8% in 2022, due to rising healthcare expenditures, increasing R&D activities, and increasing incidence of heart disease due to growth so in geriatrics. The demand for minimally invasive procedures is also a major reason the region dominates. According to data released by Cedars-Sinai in January 2022, the most common heart surgery is coronary artery bypass graft surgery (CABG)/coronary artery bypass surgery Each year, more than 300,000 patients in the United States undergo surgery prominent. This explains the increasing prevalence of heart disease in the country. 

On the other hand, Asia Pacific is expected to grow at the fastest CAGR of 10.0% during the forecast period. This can be attributed to higher healthcare expenditure, increased awareness of cardiology, better newborn screening programs and improved healthcare infrastructure in the region which affects the increased life expectancy and price of these products Manufacturers of these devices see untapped growth in this region. For example, in December 2022, Abbott announced the launch of Navitar in India. This is a less invasive transcatheter aortic valve implantation (TAVI) procedure indicated for people with severe aortic stenosis who are at high or moderate surgical risk. The new device prevents clotting around the valve Transcatheter aortic is being developed development of valve replacement therapies.